Fewer stillbirths and reduced perinatal mortality are the key findings of the first analysis of the Safer Baby Bundle, ...

Raw milk has long been at the center of passionate debate, with public health concerns often clashing against emerging ...

In South and West Dallas, initiatives like Restorative Farms have turned vacant lots into hubs for fresh produce, job ...

Combination of debt and founder’s equity will support the continued expansion of Metabolic, extending access to evidence-based, technology-enabled metabolic care across new communities in Dubai, ...

Critical care medicine (CCM) in China is entering a new phase with the release of comprehensive national guidelines that ...

The U.S. Food and Drug Administration is relaxing rules that restrict when food companies can claim their products have no ...

A Sheffield doctor leading the way in research for irritable bowel syndrome (IBS) and other gut disorders, including those ...

Doug Wolfberg’s message is clear and deliberately uncomfortable: in EMS, the standard of care is never declared in advance, ...

This new article publication from Acta Pharmaceutica Sinica B, discusses therapeutic drug monitoring of biologics in inflammatory bowel disease.

Following the frequent suspicions regarding the safety of cholesterol-lowering drugs in the pre-statin era,1 statins have been a recurrent object of various concerns and alarming news. For example, ...

New Clinical Indications Statement Expands Recommendations for Cardiac PET and Myocardial Blood Flow Quantification Based on the clinical and scientific evidence now available, there are no clinical ...

The study, conducted in the department of internal medicine, PGIMER, is the first clinical study to demonstrate the ...